This study, soon to be published in The Lancet Digital Health , was covered widely, including in ECO News, which highlighted how our approach challenges the GLP-1 status quo: Patients of an online obesity clinic achieved the same weight loss as those in clinical trials of semaglutide but with much lower doses of the drug. A new standard: dose less, support more Most semaglutide trials follow a fixed dosing schedule that escalates to 2.4 mg per week
Glutathione is often called the master antioxidant and we think it deserves the title
12/1/2025 On November 6, 2025, the Trump administration announced a landmark agreement with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to provide steep discounts on their most popular GLP-1 medications, cuts that will benefit Medicare and Medicaid enrollees as well as cash-paying patients
How to store the DSIP in the laboratory
That's why people on these drugs lose so much weight
When administered through IV therapy, glutathione is believed to be absorbed more efficiently, reaching higher concentrations in the body